By Finance Pulse in Stock Market —

BMO Capital Slashes Novo Nordisk Price Target to $105

BMO Capital cuts Novo Nordisk price target from $156 to $105. Explore the reasons behind this significant downgrade. Stay updated with financial insights.

A sleek and modern image featuring stock market charts with a focus on Novo Nordisk's logo, symboliz
BMO Capital Slashes Novo Nordisk Price Target to $105

BMO Capital reduced price targets for Novo Nordisk from $156 to $105 per share.

Source